Follicle stimulating hormone receptor mediated gene delivery to target ovarian carcinoma in vitro

被引：2
|
作者：
Dong, Chris [1 ]
Chen, Jun [2 ]
Zhang, Xiaoyan [3 ,4 ]
Xu, Congjian [1 ,3 ,4 ,5 ]
机构：
[1] Fudan Univ, Dept Obstet & Gynecol, Shanghai Med Sch, Shanghai 200000, Peoples R China
[2] Fudan Univ, Dept Pharmaceut, Sch Pharm, Shanghai 200000, Peoples R China
[3] Fudan Univ, Obstet & Gynecol Hosp, Shanghai 200000, Peoples R China
[4] Fudan Univ, Inst Biomed Sci, Shanghai 200000, Peoples R China
[5] Shanghai Key Lab Female Reprod Endocrine Related, Shanghai 200000, Peoples R China
来源：
ASIAN BIOMEDICINE | 2012年 / 6卷 / 02期
关键词：
Follice stimulating hormone peptide; follice stimulating hormone receptor; ovarian carcinoma; polyplexes; receptor mediated gene delivery; siRNA expression plasmid; EPITHELIAL-CELLS; GALACTOSE-POLY(ETHYLENE GLYCOL)-POLYETHYLENIMINE; POLYETHYLENIMINE-GRAFT-POLY(ETHYLENE GLYCOL); BLOCK-COPOLYMERS; EXPRESSION; SYSTEM; GROWTH; OLIGONUCLEOTIDES; POLYETHYLENIMINE; COMPLEXES;
D O I：
10.5372/1905-7415.0602.045
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
Background: How to deliver sufficient therapeutic genes into cancer cells while causing fewer side effects are major challenges in cancer gene therapies. Receptor mediated gene delivery enables specific delivering therapeutic genes into target cancer cells and increases the efficacy. Objectives: We developed a novel receptor mediated short interference RNA (siRNA) expression plasmid delivery system against ovarian carcinoma cells with improved biocompatibility in vitro. Methods: Follice stimulating hormone (FSH) peptide (beta: 33-55) was grafted to polyethylenimine (PEI) via a bifunctional polyethylene glycol (PEG) and complexed with anti chemokine c-x-c motif ligand 1 (CXCL1) plasmid DNA (pDNA) to form FSH-PEG-PEI/pDNA polyplexes at various N/P ratios. The cytotocity, transfection efficiency, and CXCL1 silencing effect were evaluated respectively. Results: The FSH-PEG-PEI/pDNA polyplexes showed low cytotoxicity, high transfection efficiency, and specific CXCL1 gene silencing effect. The 2% FSH-PEG-PEI conjugate complexed with pDNA at N/P ratio of 25 has better physicochemical properties. The therapeutic siRNA expression plasmid uptake by follice stimulating hormone receptor (FSHR) expression ovarian carcinoma cells was through a receptor-mediated manner. Conclusion: The FSH-PEG-PEI conjugate can be used as a novel receptor mediated gene delivery system against ovarian carcinomas. This strategy could be extended to a wide range of targeted gene therapeutics against different cancers.
引用
收藏
页码：185 / 194
页数：10
相关论文
共 50 条
  • [21] Expression of Follicle- Stimulating Hormone Receptor in Vascular Anomalies
    Maclellan, Reid A.
    Vivero, Matthew P.
    Purcell, Patricia
    Kozakewich, Harry P.
    DiVasta, Amy D.
    Mulliken, John B.
    Fishman, Steven J.
    Greene, Arin K.
    PLASTIC AND RECONSTRUCTIVE SURGERY, 2014, 133 (03) : 344E - 351E
  • [22] Transcriptional control of the MUC16 promoter facilitates follicle-stimulating hormone peptide-conjugated shRNA nanoparticle-mediated inhibition of ovarian carcinoma in vivo
    Zhang, Ming-Xing
    Hong, Shan-Shan
    Cai, Qing-Qing
    Zhang, Meng
    Chen, Jun
    Zhang, Xiao-Yan
    Xu, Cong-Jian
    DRUG DELIVERY, 2018, 25 (01) : 797 - 806
  • [23] Effects of luteinizing hormone and follicle stimulating hormone on the developmental competence of porcine preantral follicle oocytes grown in vitro
    Wu, Ji
    Xu, Bo
    Wang, Wei
    JOURNAL OF ASSISTED REPRODUCTION AND GENETICS, 2007, 24 (09) : 419 - 424
  • [24] Effects of luteinizing hormone and follicle stimulating hormone on the developmental competence of porcine preantral follicle oocytes grown in vitro
    Ji Wu
    Bo Xu
    Wei Wang
    Journal of Assisted Reproduction and Genetics, 2007, 24 : 419 - 424
  • [25] Opposed roles of follicle-stimulating hormone and luteinizing hormone receptors in ovarian cancer survival
    Lenhard, Miriam
    Lennerova, Tereza
    Ditsch, Nina
    Kahlert, Steffen
    Friese, Klaus
    Mayr, Doris
    Jeschke, Udo
    HISTOPATHOLOGY, 2011, 58 (06) : 990 - 994
  • [26] Secreting Follicle-Stimulating Hormone Pituitary Carcinoma with Cervical Metastasis
    Grandidge, Carly
    Hall, Andy
    Kitchen, Neil
    WORLD NEUROSURGERY, 2016, 93 : 490.e13 - 490.e16
  • [27] Immunohistochemical detection of follicle stimulating hormone receptor (FSHR) in neuroendocrine tumours
    Pawlikowski, Marek
    Winczyk, Katarzyna
    Stepien, Henryk
    ENDOKRYNOLOGIA POLSKA, 2013, 64 (04) : 268 - 271
  • [28] Progesterone and Follicle Stimulating Hormone interact and promote goat preantral follicles survival and development in vitro
    Lima-Verde, Isabel B.
    Matos, Maria H. T.
    Celestino, Juliana J. H.
    Rossetto, Rafael
    Name, Khesller P. O.
    Bao, Sonia N.
    Campello, Claudio C.
    Figueiredo, Jose R.
    PESQUISA VETERINARIA BRASILEIRA, 2012, 32 (04): : 361 - 367
  • [29] Small Molecule Follicle-Stimulating Hormone Receptor Agonists and Antagonists
    Anderson, Ross C.
    Newton, Claire L.
    Millar, Robert P.
    FRONTIERS IN ENDOCRINOLOGY, 2019, 9
  • [30] Patients with endometriosis and patients with poor ovarian reserve have abnormal follicle-stimulating hormone receptor signaling pathways
    Gonzalez-Fernandez, Rebeca
    Pena, Oscar
    Hernandez, Jairo
    Martin-Vasallo, Pablo
    Palumbo, Angela
    Avila, Julio
    FERTILITY AND STERILITY, 2011, 95 (07) : 2373 - 2378
12345